2023年6月22日

新聞分享這篇文章分享這篇文章提供的新加坡,6月22日,2023ζ從外科手術機器人和混合現實公司首次成功治療病人使用ζ顱導航係統作為first-in-human試驗的一部分,新加坡國立神經科學研究所(NNI)。醫院的臨床試驗在NNI,躋身全球十大醫院根據《新聞周刊》,旨在評估安全性、有效性和可行性pin-less床邊腦室切開術ζ顱導航係統的程序。審判由NNI副顧問陳分魏博士,新加坡總醫院和tank Tock Seng醫院。“我非常深刻的印象與底層技術及其準確性,”陳博士說。“我們很高興成為第一個機構運行這個試驗對人類患者,已經成功在我們的第一個參與者有前途的早期結果。我們期待接下來的審判。”Dr. William Gormley, Chief Medical Officer of Zeta Surgical and Harvard Medical School Associate Professor, commented on the study: "Placing a navigated bedside ventricular catheter in a mobile, non-cranially-pinned patient is truly a landmark accomplishment. It brings the extraordinary precision found in the neurosurgical operating room of select institutions in the world to all patients, irrespective of if they are in the emergency room, the intensive care unit, or the operating room. It is truly an accomplishment that democratizes medicine and will make an enormous difference across a broad range of procedures." "This trial marks our first step towards making surgical guidance truly accessible across neurosurgery and neuroscience," says Raahil Sha, Co-Founder and Chief Technology Officer of Zeta Surgical. "We are thrilled to be partnering with NNI in our mission to make surgeries more precise, safe, and effective." About Zeta Surgical Zeta Surgical is a digital surgery company focused on improving the accuracy, safety, and accessibility of image guided procedures. Its navigation and robotics platform, Zeta, leverages cutting-edge computer vision and artificial intelligence to enable image guidance directly at the point-of-care, creating new possibilities in fields such as emergency care, interventional medicine, and drug delivery. Zeta Surgical was founded by Harvard graduates and faculty and is backed by leading investors. To learn more, visit: www.zetasurgical.com . Contact: